IRT

Welcome to the Brand page for “IRT”, which is offered here for Cancer therapy, the use of mono clonal antibodies and radioisotopes in humans to combine the therapeutic effects of the mono clonal antibody and radioisotopes;.

Its status is currently believed to be active. Its class is unavailable. “IRT” is believed to be currently owned by “AltaRex Corp.”


Owner:
ALTAREX CORP.
Owner Details
Description:
Cancer therapy, the use of mono clonal antibodies and radioisotopes in humans to combine the therapeutic effects of the mono clonal antibody and radioisotopes;
Categories: CANCER THERAPY